4.4 Article

Mechanisms of surgical control of type 2 diabetes: GLP-1 is the key factor-Maybe

期刊

SURGERY FOR OBESITY AND RELATED DISEASES
卷 12, 期 6, 页码 1230-1235

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.soard.2016.05.008

关键词

Gastric bypass surgery; GLP-1; Hyperinsulinemia; Diabetes; Hypoglycemia

类别

资金

  1. National Institutes of Health [DK105379, DK083554, DK101991]

向作者/读者索取更多资源

Bariatric surgery is the most effective treatment for obesity and diabetes. The 2 most commonly performed weight-loss procedures, Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy, improve glycemic control in patients with type 2 diabetes independent of weight loss. One of the early hypotheses raised to explain the immediate antidiabetic effect of RYGB was that rapid delivery of nutrients from the stomach pouch into the distal small intestine enhances enterolnsular signaling to promote insulin signaling. Given the tenfold increase in postmeal glucagon-like peptide-1 (GLP-1) response compared to unchanged integrated levels of postprandial glucose-dependent insulinotropic peptide after RYGB, enhanced meal-induced insulin secretion after this procedure was thought to be the result of elevated glucose and GLP-1 levels. In this contribution to the larger point counterpoint debate about the role of GLP-1 after bariatric surgery, most of the focus will be on RYGB. (C) 2016 American Society for Metabolic and Bariatric Surgery. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据